Bazil Carl W.
The Neurological Institute, Columbia University, 710 West 168 Street, New York, NY 10032, USA.
Curr Treat Options Neurol. 2004 Jul;6(4):339-345. doi: 10.1007/s11940-004-0033-4.
Sleep disorders occur commonly in patients with epilepsy, and can be responsible for symptoms of daytime somnolence and also can contribute to the intractability of epilepsy. The most important aspect of treating sleep disorders, especially sleep apnea, is the recognition of the problem. In a busy clinical practice, symptoms of sleep disorders are frequently overlooked or mistaken. Whenever sleep disruption or excessive daytime somnolence is potentially problematic, the patient should be referred to a sleep specialist and, if indicated, diagnostic testing performed (usually polysomnography with or without multiple sleep latency tests). The author also recommends that all patients receive basic counseling about sleep hygiene, because its principles are often helpful to patients in general. Even in the absence of a sleep disorder, the choice of an anticonvulsant can be partly tailored to the sleep needs of the patient, with alerting drugs (lamotrigine and felbamate) dosed early in the day and relatively sedating agents (phenobarbital and phenytoin) dosed later or at bedtime.
睡眠障碍在癫痫患者中很常见,可导致白天嗜睡症状,还可能导致癫痫难以治疗。治疗睡眠障碍,尤其是睡眠呼吸暂停的最重要方面是认识到这个问题。在繁忙的临床实践中,睡眠障碍的症状经常被忽视或误诊。每当睡眠中断或白天过度嗜睡可能有问题时,患者应转诊至睡眠专家处,并在必要时进行诊断测试(通常是多导睡眠图检查,可进行或不进行多次睡眠潜伏期测试)。作者还建议所有患者接受关于睡眠卫生的基本咨询,因为其原则通常对一般患者都有帮助。即使没有睡眠障碍,抗惊厥药物的选择也可以部分根据患者的睡眠需求进行调整,刺激性药物(拉莫三嗪和非氨酯)在一天中较早时候给药,而相对具有镇静作用的药物(苯巴比妥和苯妥英)在较晚时候或睡前给药。